The common analogy of drug action is that of a lock and key, with a drug acting as a selective 'key' that fits into the 'lock' of a specific drug target. Over the past two decades, the concept of ...

The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according ...